ALTIMMUNE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.010 USD | -6.54% |
|
+2.50% | -19.91% |
Chart calendar Altimmune, Inc.
03.YQEr-l7riEIE7RH2agknEByED9t7aC--Xpi0DgcUYNE.KWVEghGf6XZll1KZAGZjdU7dY-01EHfWBNXRYn5nBqsRbGa_NKSlEHa7Yg~9049f6dd3356158f4a6dfb543ac1ceda
Upcoming events on Altimmune, Inc.
Past events on Altimmune, Inc.
| 2024-12-06 09:30 | Society on Sarcopenia Cachexia & Wasting Disorders International Conference |
| 2024-12-04 15:30 | Piper Sandler Healthcare Conference |
| 2024-12-03 10:50 | Evercore ISI HealthCONx Conference |
| 2024-11-15 16:00 | American Association for the Study of Liver Disease Meeting |
| 2024-11-13 12:30 | UBS Global Healthcare Conference |
| 2024-11-12 08:30 | Q3 2024 Earnings Call |
| 2024-11-12 07:00 | Q3 2024 Earnings Release |
| 2024-11-11 11:30 | Guggenheim Securities Healthcare Innovation Conference |
| 2024-10-07 11:30 | H.C. Wainwright MASH Virtual Conference |
| 2024-09-25 | Annual General Meeting |
| 2024-09-10 07:45 | European Association for the Study of Diabetes Meeting - Session 038, Oral Presentation 557 |
| 2024-08-08 08:30 | Q2 2024 Earnings Call |
| 2024-08-08 07:00 | Q2 2024 Earnings Release |
| 2024-07-08 | Leerink Partners Therapeutics I&I and Metabolism Forum |
| 2024-06-26 09:30 | Piper Sandler Virtual Obesity Investor Day - Fireside Chat |
| 2024-06-23 13:45 | American Diabetes Association Scientific Symposium |
| 2024-06-22 16:45 | American Diabetes Association Scientific Symposium |
| 2024-06-12 09:20 | Goldman Sachs Global Healthcare Conference - Fireside Chat |
| 2024-06-05 14:00 | Jefferies Global Healthcare Conference |
| 2024-06-05 02:30 | European Association for the Study of the Liver Congress - Abstract Number: 3002 |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 4,41 1,18 274.08% | -0,07 0,05 -241.67% | 0,43 0,34 24.04% | 0,01 | 25,0 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -96,4 -92,2 -4.51% | -87,9 -89,3 1.53% | -95,5 -83,1 -14.86% | -101 | -119 | -140 |
|
EBIT Million USD | Released Forecast Spread | -85,5 -97,5 12.28% | -87,7 -91,4 3.99% | -83,5 -93,9 11.09% | -104 | -109 | -180 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -97,1 -99,3 2.24% | -84,9 -91,2 6.88% | -88,4 -81,2 -8.96% | -95,8 | -102 | -176 |
|
Net income Million USD | Released Forecast Spread | -97,1 -98,7 1.64% | -84,7 -90,9 6.82% | -88,4 -81,1 -9.1% | -95,8 | -102 | -176 |
|
EPS USD | Released Forecast Spread | -2,35 -2,41 2.62% | -1,81 -2,04 11.09% | -1,66 -1,47 -13.18% | -1,34 | -1,19 | -1,69 |
| Announcement Date | 15/03/22 | 28/02/23 | 27/03/24 | - |
Quarterly results
| Fiscal Period | September | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,02 0,00 - | 0,01 0,00 100% | 0,36 0,00 41993.02% | 0,04 0,00 1628.97% | 0,01 0,00 - | 0,01 0,00 706.45% | 0,01 0,00 706.45% | 0,00 | 0,00 | 40,0 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -21,4 -23,9 10.45% | -17,5 -21,7 19.35% | -22,0 -18,1 -21.48% | -31,7 -19,4 -63.57% | -26,7 -21,8 -22.42% | -26,7 -19,9 -34.09% | -24,7 -20,4 -21.23% | -20,9 | |||||||
|
EBIT Million USD | Released Forecast Spread | -21,8 -24,8 12.15% | -18,0 -24,3 25.94% | -22,5 -22,6 0.37% | -21,2 -34,9 39.23% | -26,8 -23,7 -13.28% | -26,7 -25,2 -5.99% | -24,8 -26,4 6.03% | -25,3 | -31,1 | 32,7 | -38,0 | -42,6 | -40,3 | -42,6 | -45,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -20,1 -24,6 18.35% | -16,1 -23,5 31.54% | -20,7 -21,6 4.4% | -31,6 -24,4 -29.94% | -24,4 -22,9 -6.37% | -24,6 -24,2 -1.94% | -22,8 -25,4 10.03% | -24,2 | -29,2 | 34,5 | -35,4 | -40,4 | -38,2 | -40,5 | -42,9 |
|
Net income Million USD | Released Forecast Spread | -20,1 -24,5 18.02% | -16,1 -16,3 1.52% | -20,7 -21,5 3.79% | -31,6 -24,3 -30.25% | -24,4 -22,8 -7.1% | -24,6 -24,8 0.55% | -22,8 -25,7 10.96% | -24,2 | -29,2 | 34,5 | -35,4 | -40,4 | -38,2 | -40,5 | -42,9 |
|
EPS USD | Released Forecast Spread | -0,40 -0,48 16.67% | -0,32 -0,45 29.41% | -0,39 -0,42 6.4% | -0,54 -0,38 -44% | -0,34 -0,36 5.99% | -0,35 -0,35 -1.45% | -0,32 -0,36 10.85% | -0,33 | -0,38 | 0,21 | -0,38 | -0,42 | -0,44 | -0,46 | -0,48 |
| Announcement Date | 11/05/23 | 10/08/23 | 07/11/23 | 27/03/24 | 09/05/24 | 08/08/24 | 12/11/24 | - | - | - | - | - | - | - | - |
More events
Past sector events for Altimmune, Inc.
| 2024-12-09 06:16 | LUMOSA THERAPEUTICS CO., LTD.: November 2024 Sales and Revenue Release |
| 2024-12-05 04:03 | PHARMAESSENTIA CORPORATION: November 2024 Sales and Revenue Release |
| 2024-11-26 16:00 | ARROWHEAD PHARMACEUTICALS, INC.: Q4 2024 Earnings Release |
| 2024-11-24 | ANAVEX LIFE SCIENCES CORP.: Q4 2024 Earnings Release (Projected) |
| 2024-11-18 07:00 | IMMATICS N.V.: Q3 2024 Earnings Release |
| 2024-11-14 16:01 | CELCUITY INC.: Q3 2024 Earnings Release |
| 2024-11-14 16:01 | ASCENDIS PHARMA A/S: Q3 2024 Earnings Release |
| 2024-11-14 08:00 | ANNEXON, INC.: Q3 2024 Earnings Release |
| 2024-11-14 04:09 | PHARMAESSENTIA CORPORATION: Q3 2024 Earnings Release |
| 2024-11-13 | PEPTRON, INC.: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALT Stock
- Calendar Altimmune, Inc.
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition